Lowe, Emily L <br/><br/>
Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.  [electronic resource] 

 -  PloS one  Sep 2010 
 - e13027 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1932-6203 
<br/><br/><label>Standard No.: </label>10.1371/journal.pone.0013027  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aberrant Crypt Foci--etiology<br/>Animals<br/>Colitis--complications<br/>Colorectal Neoplasms--etiology<br/>Disease Models, Animal<br/>Female<br/>Humans<br/>Immunity, Innate<br/>Interleukin-6--immunology<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mice, Knockout<br/>Neoplastic Processes<br/>Signal Transduction<br/>Toll-Like Receptor 2--genetics